Arshad Khanani, MD: A Breakthrough in Geographic Atrophy Treatment
One of the most notable topics discussed at the 2022 American Academy of Ophthalmology Meeting in Chicago was new advancements in geographic atrophy (GA) treatment.
A form of advanced age-related macular degeneration (AMD), there are no currently available treatments for the debilitating disease.
In this episode of DocTalk, we spoke with Arshad Khanani, MD, Director of Clinical Research, Sierra Eye Associates, on the findings from the GATHER2 trial on avacincaptad pegol for the treatment of GA.
Throughout our conversation, Khanani laid out the first-time efficacy results of the phase 3 trial…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.